Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.65 USD | -0.60% | -1.79% | -23.08% |
Business Summary
Number of employees: 380
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Clinical Laboratory Goods
74.4
%
| 58 | 78.0 % | 42 | 74.4 % | -27.46% |
Point-of-Care
16.0
%
| 9 | 12.3 % | 9 | 16.0 % | -1.32% |
Clinical Laboratory Services
9.6
%
| 7 | 9.7 % | 5 | 9.6 % | -25.01% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Americas
79.2
%
| 51 | 67.5 % | 45 | 79.2 % | -10.94% |
Ireland
20.8
%
| 24 | 32.5 % | 12 | 20.8 % | -51.18% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
John Gillard
CEO | Chief Executive Officer | 43 | 20-11-16 |
Ronan O'Caoimh
FOU | Founder | 68 | 92-05-31 |
Cormac Reynolds
COO | Chief Operating Officer | - | 20-12-31 |
Eibhlin Kelly
CTO | Chief Tech/Sci/R&D Officer | 40 | 15-08-31 |
Gary Keating
CTO | Chief Tech/Sci/R&D Officer | 51 | 22-09-30 |
Thomas Lindsay
BRD | Director/Board Member | 66 | 22-10-25 |
Jim Walsh
BRD | Director/Board Member | 65 | 95-09-30 |
Nick O’Hare
SAM | Sales & Marketing | - | 21-12-31 |
Colm Molloy
HRO | Human Resources Officer | 53 | 20-12-31 |
Ian Wells
LAW | General Counsel | 55 | 22-08-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Ronan O'Caoimh
FOU | Founder | 68 | 92-05-31 |
Jim Walsh
BRD | Director/Board Member | 65 | 95-09-30 |
Thomas Lindsay
BRD | Director/Board Member | 66 | 22-10-25 |
John Gillard
CEO | Chief Executive Officer | 43 | 20-11-16 |
Andrew Omidvar
BRD | Director/Board Member | - | 23-09-28 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 2 | 700,000 | 0 | 0 | 89.35 % |
Stock B | 1 | 33,077,257 | 30,181,196 ( 91.24 %) | 2,511,200 ( 7.592 %) |
Company contact information
Sector
Sales per Business
Sales per region
1st Jan change | Capi. | |
---|---|---|
-23.08% | 15.71M | |
-1.34% | 12.58B | |
-1.64% | 8.51B | |
+0.09% | 5.29B | |
+22.42% | 5.16B | |
-0.09% | 4.55B | |
-52.84% | 3.04B | |
+20.02% | 3B | |
+31.92% | 2.17B | |
-2.45% | 1.92B |
- Stock Market
- Equities
- TRIB Stock
- Company Trinity Biotech plc